Literature DB >> 19668245

Managing bipolar disorders in children and adolescents.

Eric Taylor1.   

Abstract

Bipolar disorders are recurrent disturbances in mood that include periods both of depression and mania. Classic bipolar disorders, with manic episodes lasting for at least several days, often start in adolescence, but are uncommon in earlier childhood. Treatment of mania in young patients should include ensuring the individual's safety, and administration of a mood-stabilizing drug, or, in severe cases, a neuroleptic. Prophylaxis with lithium or an anticonvulsant should then be considered. In younger children, brief outbursts of excessive emotion--especially anger--should be recognized as a notable clinical problem. These outbursts do not necessarily constitute the beginnings of a classic bipolar disorder, but should trigger a diagnostic differential that also includes attention-deficit hyperactivity disorder, reaction to hostile environments, severe mood dysregulation, substance misuse, and autism spectrum disorders.

Entities:  

Mesh:

Year:  2009        PMID: 19668245     DOI: 10.1038/nrneurol.2009.117

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  61 in total

1.  Prepubertal and early adolescent bipolarity differentiate from ADHD by manic symptoms, grandiose delusions, ultra-rapid or ultradian cycling.

Authors:  B Geller; M Williams; B Zimerman; J Frazier; L Beringer; K L Warner
Journal:  J Affect Disord       Date:  1998-11       Impact factor: 4.839

Review 2.  Child and adolescent bipolar disorder: a review of the past 10 years.

Authors:  B Geller; J Luby
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1997-09       Impact factor: 8.829

3.  Naturalistic experience with the use of divalproex sodium on an in-patient unit for adolescent psychiatric patients.

Authors:  J A Deltito; J Levitan; J Damore; F Hajal; M Zambenedetti
Journal:  Acta Psychiatr Scand       Date:  1998-03       Impact factor: 6.392

Review 4.  Juvenile bipolar disorder.

Authors:  Y C Reddy; S Srinath
Journal:  Acta Psychiatr Scand       Date:  2000-09       Impact factor: 6.392

5.  Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression.

Authors:  C B Nemeroff; D L Evans; L Gyulai; G S Sachs; C L Bowden; I P Gergel; R Oakes; C D Pitts
Journal:  Am J Psychiatry       Date:  2001-06       Impact factor: 18.112

6.  Long-term outcome with divalproex in children and adolescents with bipolar disorder.

Authors:  Charles A Henry; Linda S Zamvil; Christopher Lam; Klara J Rosenquist; S Nassir Ghaemi
Journal:  J Child Adolesc Psychopharmacol       Date:  2003       Impact factor: 2.576

7.  Prevalence and development of psychiatric disorders in childhood and adolescence.

Authors:  E Jane Costello; Sarah Mustillo; Alaattin Erkanli; Gordon Keeler; Adrian Angold
Journal:  Arch Gen Psychiatry       Date:  2003-08

8.  Efficacy of tricyclic drugs in treating child and adolescent depression: a meta-analysis.

Authors:  P Hazell; D O'Connell; D Heathcote; J Robertson; D Henry
Journal:  BMJ       Date:  1995-04-08

9.  Olanzapine versus placebo in the treatment of adolescents with bipolar mania.

Authors:  Mauricio Tohen; Ludmila Kryzhanovskaya; Gabrielle Carlson; Melissa Delbello; Janet Wozniak; Robert Kowatch; Karen Wagner; Robert Findling; Daniel Lin; Carol Robertson-Plouch; Wen Xu; Ralf W Dittmann; Joseph Biederman
Journal:  Am J Psychiatry       Date:  2007-10       Impact factor: 18.112

10.  Lithium treatment of acute mania in adolescents: a placebo-controlled discontinuation study.

Authors:  Vivian Kafantaris; Daniel J Coletti; Robert Dicker; Gina Padula; Richard R Pleak; Jose Maria J Alvir
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2004-08       Impact factor: 8.829

View more
  3 in total

Review 1.  Clinical staging in the pathophysiology of psychotic and affective disorders: facilitation of prognosis and treatment.

Authors:  Trevor Archer; Richard M Kostrzewa; Tomas Palomo; Richard J Beninger
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

Review 2.  Emerging treatment options in bipolar disorder in adolescents: focus on ziprasidone.

Authors:  Afshan A Khan; Jeffrey R Strawn; Paul E Croarkin
Journal:  Adolesc Health Med Ther       Date:  2010-10-11

3.  Cerebrospinal fluid metabolomics identifies a key role of isocitrate dehydrogenase in bipolar disorder: evidence in support of mitochondrial dysfunction hypothesis.

Authors:  N Yoshimi; T Futamura; S E Bergen; Y Iwayama; T Ishima; C Sellgren; C J Ekman; J Jakobsson; E Pålsson; K Kakumoto; Y Ohgi; T Yoshikawa; M Landén; K Hashimoto
Journal:  Mol Psychiatry       Date:  2016-01-19       Impact factor: 15.992

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.